Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Current Treatment Options in Oncology | journal | 1.118 Q2 | 66 | 119 | 300 | 8715 | 1486 | 297 | 4.17 | 73.24 | 49.13 | |
52 | Clinical Genitourinary Cancer | journal | 1.031 Q2 | 57 | 158 | 515 | 4584 | 1508 | 493 | 3.11 | 29.01 | 27.98 | |
53 | Prostate | journal | 1.015 Q2 | 135 | 167 | 474 | 6818 | 1600 | 464 | 2.90 | 40.83 | 30.40 | |
54 | Cancer Biology and Therapy | journal | 0.996 Q2 | 130 | 64 | 356 | 2710 | 1604 | 354 | 3.28 | 42.34 | 38.20 | |
55 | Current Opinion in Oncology | journal | 0.971 Q2 | 104 | 103 | 275 | 5423 | 919 | 256 | 3.20 | 52.65 | 47.16 | |
56 | Pediatric Blood and Cancer | journal | 0.962 Q2 | 128 | 581 | 1807 | 15952 | 4563 | 1313 | 2.39 | 27.46 | 58.27 | |
57 | JTO Clinical and Research Reports | journal | 0.923 Q2 | 18 | 145 | 191 | 3604 | 458 | 178 | 2.40 | 24.86 | 37.18 | |
58 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.916 Q2 | 90 | 81 | 402 | 2740 | 975 | 368 | 2.55 | 33.83 | 41.26 | |
59 | Current Hematologic Malignancy Reports | journal | 0.914 Q2 | 44 | 31 | 162 | 2200 | 569 | 162 | 3.06 | 70.97 | 53.41 | |
60 | Cancer Nanotechnology | journal | 0.882 Q2 | 36 | 42 | 59 | 2014 | 380 | 57 | 4.96 | 47.95 | 43.21 | |
61 | Cancer journal (Sudbury, Mass.) | journal | 0.880 Q2 | 102 | 70 | 217 | 4548 | 487 | 198 | 1.93 | 64.97 | 37.07 | |
62 | Urologic Oncology: Seminars and Original Investigations | journal | 0.874 Q2 | 85 | 323 | 887 | 9611 | 2494 | 863 | 2.66 | 29.76 | 24.27 | |
63 | Journal of Psychosocial Oncology | journal | 0.873 Q2 | 52 | 57 | 170 | 2218 | 545 | 165 | 2.67 | 38.91 | 66.32 | |
64 | Hematology/Oncology Clinics of North America | journal | 0.866 Q2 | 95 | 90 | 271 | 6577 | 730 | 234 | 2.00 | 73.08 | 49.35 | |
65 | Clinical Breast Cancer | journal | 0.862 Q2 | 80 | 202 | 444 | 8147 | 1370 | 427 | 3.10 | 40.33 | 54.71 | |
66 | Practical Radiation Oncology | journal | 0.847 Q2 | 51 | 150 | 458 | 3237 | 1012 | 401 | 2.39 | 21.58 | 38.94 | |
67 | Journal of Surgical Oncology | journal | 0.836 Q2 | 131 | 362 | 1215 | 11582 | 3163 | 1055 | 2.33 | 31.99 | 33.20 | |
68 | Journal of Oncology (discontinued) | journal | 0.805 Q2 | 68 | 950 | 890 | 39506 | 3224 | 880 | 3.04 | 41.59 | 40.84 | |
69 | Oncotarget | journal | 0.801 Q2 | 177 | 138 | 1361 | 5047 | 3412 | 1216 | 2.56 | 36.57 | 42.72 | |
70 | Advances in Radiation Oncology | journal | 0.791 Q2 | 36 | 216 | 526 | 6089 | 1296 | 486 | 2.31 | 28.19 | 35.19 | |
71 | Medical Oncology | journal | 0.777 Q2 | 90 | 256 | 355 | 13998 | 1098 | 333 | 3.13 | 54.68 | 43.36 | |
72 | Neuro-Oncology Practice | journal | 0.769 Q2 | 29 | 73 | 231 | 2228 | 612 | 205 | 2.37 | 30.52 | 46.15 | |
73 | Integrative Cancer Therapies | journal | 0.766 Q2 | 71 | 98 | 350 | 5073 | 1146 | 329 | 2.73 | 51.77 | 56.19 | |
74 | World Journal of Gastrointestinal Oncology | journal | 0.762 Q2 | 42 | 187 | 371 | 9953 | 1127 | 368 | 2.97 | 53.22 | 38.88 | |
75 | Radiology: Imaging Cancer | journal | 0.761 Q2 | 18 | 61 | 183 | 755 | 368 | 117 | 2.04 | 12.38 | 33.18 | |
76 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.758 Q2 | 65 | 765 | 722 | 9334 | 1519 | 690 | 2.08 | 12.20 | 45.11 | |
77 | Molecular Imaging and Biology | journal | 0.748 Q2 | 78 | 99 | 401 | 4160 | 1266 | 381 | 3.13 | 42.02 | 36.70 | |
78 | Brachytherapy | journal | 0.741 Q2 | 57 | 114 | 389 | 3667 | 785 | 370 | 1.87 | 32.17 | 32.45 | |
79 | Melanoma Research | journal | 0.740 Q2 | 80 | 73 | 280 | 2106 | 727 | 262 | 2.12 | 28.85 | 45.12 | |
80 | JMIR Cancer | journal | 0.724 Q2 | 24 | 81 | 110 | 3798 | 355 | 110 | 2.83 | 46.89 | 56.73 | |
81 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.705 Q2 | 112 | 16 | 91 | 1231 | 209 | 86 | 2.22 | 76.94 | 55.29 | |
82 | European Journal of Cancer Prevention | journal | 0.698 Q3 | 88 | 83 | 242 | 3220 | 517 | 211 | 2.05 | 38.80 | 51.00 | |
83 | Immuno-Oncology and Technology | journal | 0.691 Q3 | 10 | 8 | 33 | 524 | 67 | 25 | 1.65 | 65.50 | 50.00 | |
84 | Oncology Research | journal | 0.658 Q3 | 76 | 24 | 249 | 1456 | 804 | 240 | 2.19 | 60.67 | 39.19 | |
85 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.650 Q3 | 68 | 108 | 260 | 4014 | 897 | 255 | 3.81 | 37.17 | 37.69 | |
86 | Head and Neck Pathology | journal | 0.650 Q3 | 67 | 130 | 431 | 4591 | 1163 | 422 | 2.47 | 35.32 | 42.19 | |
87 | Journal of Cancer Education | journal | 0.648 Q3 | 52 | 251 | 525 | 6738 | 1098 | 493 | 1.79 | 26.84 | 58.32 | |
88 | Nutrition and Cancer | journal | 0.634 Q3 | 130 | 378 | 546 | 18933 | 1940 | 540 | 3.62 | 50.09 | 50.97 | |
89 | Cancer Nursing | journal | 0.632 Q3 | 86 | 116 | 379 | 4572 | 915 | 342 | 2.20 | 39.41 | 70.79 | |
90 | Journal of Adolescent and Young Adult Oncology | journal | 0.625 Q3 | 32 | 86 | 288 | 2898 | 615 | 282 | 2.20 | 33.70 | 66.48 | |
91 | Journal of Cancer Metastasis and Treatment | journal | 0.619 Q3 | 16 | 49 | 202 | 3675 | 477 | 193 | 1.82 | 75.00 | 41.05 | |
92 | Current Problems in Cancer | journal | 0.612 Q3 | 47 | 57 | 242 | 2596 | 532 | 232 | 2.34 | 45.54 | 44.80 | |
93 | Cancer Investigation | journal | 0.598 Q3 | 93 | 88 | 215 | 3686 | 440 | 202 | 2.11 | 41.89 | 41.40 | |
94 | Technology in Cancer Research and Treatment | journal | 0.596 Q3 | 72 | 231 | 746 | 11277 | 2136 | 736 | 2.47 | 48.82 | 41.05 | |
95 | Current Opinion in Supportive and Palliative Care | journal | 0.595 Q3 | 50 | 41 | 153 | 1655 | 341 | 132 | 1.88 | 40.37 | 52.94 | |
96 | Sarcoma | journal | 0.549 Q3 | 53 | 16 | 89 | 470 | 188 | 89 | 1.78 | 29.38 | 36.89 | |
97 | Cancer Control | journal | 0.548 Q3 | 80 | 177 | 324 | 7730 | 805 | 313 | 2.37 | 43.67 | 45.83 | |
98 | Journal of the Canadian Urological Association | journal | 0.515 Q3 | 47 | 139 | 578 | 3342 | 696 | 476 | 1.10 | 24.04 | 29.10 | |
99 | Surgical Oncology Clinics of North America | journal | 0.510 Q3 | 68 | 58 | 184 | 3257 | 390 | 148 | 1.73 | 56.16 | 51.05 | |
100 | Anti-Cancer Drugs | journal | 0.471 Q3 | 102 | 239 | 427 | 7385 | 962 | 426 | 2.25 | 30.90 | 40.90 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®